临时经静脉膈神经刺激在撤机困难患者中的随机临床研究
这项多中心、开放标签、随机对照研究纳入机械通气≥4天且至少两次撤机失败的患者,比较临时经静脉多电极中心静脉导管行双侧膈神经刺激联合标准治疗(n=57)与仅标准治疗(n=55)。主要终点撤机成功率在治疗组82%、对照组74%,绝对差7%(95%CI -10至25),P=0.59,无统计学差异。最大吸气压力治疗组增加16.6 cm H2O、对照组增加4.8 cm H2O(差值11.8,95%CI 5至19),P=0.001;无辅助自主呼吸时右侧膈肌增厚分数分别为+17%和-14%,P=0.006。作者认为刺激未提高撤机比例,但与最大吸气压力显著增加相关,提示可能逆转膈肌功能障碍的进程。
要点
- 主要终点撤机成功率:治疗组82% vs 对照组74%,绝对差7%(95%CI -10至25),P=0.59,未达统计学显著。
- 最大吸气压力:治疗组增加16.6 cm H2O vs 对照组增加4.8 cm H2O(差值11.8,95%CI 5至19),P=0.001。
- 无辅助自主呼吸时右侧膈肌增厚分数:治疗组+17% vs 对照组-14%,P=0.006,且与最大吸气压力变化无相关性。
- 机械通气时长:治疗组12.7±9.9天 vs 对照组14.1±10.8天,P=0.50;两组严重不良事件频率相似。
- 治疗组刺激相关疼痛中位数为0(无疼痛);7例导管无法置入、另7例无法实施起搏治疗。
适用人群与场景
- 年龄≥18岁、有创机械通气≥4天且至少两次撤机失败的患者,多中心研究场景。
处置流程与药物剂量
- 治疗组接受临时经静脉膈神经刺激:使用多电极刺激中心静脉导管行双侧膈神经刺激,联合标准治疗。
- 对照组仅接受标准治疗。
研究设计与关键结果
- 研究类型:多中心、开放标签、随机对照研究;治疗组n=57,对照组n=55;7例导管无法置入、另7例无法实施起搏治疗,最终43例有数据。
- 主要终点撤机成功率:治疗组82% vs 对照组74%,绝对差7%(95%CI -10至25),P=0.59。
- 机械通气时长:治疗组12.7±9.9天 vs 对照组14.1±10.8天,P=0.50。
- 最大吸气压力:治疗组增加16.6 cm H2O vs 对照组增加4.8 cm H2O,差值11.8(95%CI 5至19),P=0.001。
- 无辅助自主呼吸时右侧膈肌增厚分数:治疗组+17% vs 对照组-14%,P=0.006,与最大吸气压力变化无相关性。
- 两组严重不良事件频率相似;治疗组刺激相关疼痛中位数为0(无疼痛)。
证据类型、等级与局限
- 证据类型:多中心、开放标签、随机对照研究;临床试验注册号NCT03096639及CIV-17-06-020004。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,临时经静脉膈神经刺激未提高撤机成功率,但与最大吸气压力显著增加相关,提示可能逆转膈肌功能障碍的进程。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Rationale: Diaphragm dysfunction is frequently observed in critically ill patients with difficult weaning from mechanical ventilation. Objectives: To evaluate the effects of temporary transvenous diaphragm neurostimulation on weaning outcome and maximal inspiratory pressure. Methods: Multicenter, open-label, randomized, controlled study. Patients aged ⩾18 years on invasive mechanical ventilation for ⩾4 days and having failed at least two weaning attempts received temporary transvenous diaphragm neurostimulation using a multielectrode stimulating central venous catheter (bilateral phrenic stimulation) and standard of care (treatment) (n = 57) or standard of care (control) (n = 55). In seven patients, the catheter could not be inserted, and in seven others, pacing therapy could not be delivered; consequently, data were available for 43 patients. The primary outcome was the proportion of patients successfully weaned. Other endpoints were mechanical ventilation duration, 30-day survival, maximal inspiratory pressure, diaphragm-thickening fraction, adverse events, and stimulation-related pain. Measurements and Main Results: The incidences of successful weaning were 82% (treatment) and 74% (control) (absolute difference [95% confidence interval (CI)], 7% [-10 to 25]), P = 0.59. Mechanical ventilation duration (mean ± SD) was 12.7 ± 9.9 days and 14.1 ± 10.8 days, respectively, P = 0.50; maximal inspiratory pressure increased by 16.6 cm H2O and 4.8 cm H2O, respectively (difference [95% CI], 11.8 [5 to 19]), P = 0.001; and right hemidiaphragm thickening fraction during unassisted spontaneous breathing was +17% and -14%, respectively, P = 0.006, without correlation with changes in maximal inspiratory pressure. Serious adverse event frequency was similar in both groups. Median stimulation-related pain in the treatment group was 0 (no pain). Conclusions: Temporary transvenous diaphragm neurostimulation did not increase the proportion of successful weaning from mechanical ventilation. It was associated with a significant increase in maximal inspiratory pressure, suggesting reversal of the course of diaphragm dysfunction. Clinical trial registered with www.clinicaltrials.gov (NCT03096639) and the European Database on Medical Devices (CIV-17-06-020004).
参考来源
- Dres M, de Abreu MG, Merdji H, et al. Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients. Am J Respir Crit Care Med. 2022. PMID: 35108175. doi:10.1164/rccm.202107-1709OC
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。